Trials / Completed
CompletedNCT01705639
Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene
Does Melatonin Treatment Affect Glucose Tolerance Among Individuals With a Variant (rs10830963) of the Melatonin Receptor 1B (MTNR1B) Gene?
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- University of Helsinki · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants of the melatonin receptor 1B gene will be evaluated. The following will be done at 0 and 3 months: * OGTT * questionnaires about sleep and activity * Actigraph * Anthropometry * Blood pressure
Detailed description
http://www.sciencedirect.com/science/article/pii/S1550413116301607
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin | All subjects receive the same dose of melatonin |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2012-10-12
- Last updated
- 2017-01-04
Locations
2 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT01705639. Inclusion in this directory is not an endorsement.